You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Talazoparib

Showing 76 - 100 of 107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)

Recruiting
  • Prostate Cancer
  • talazoparib plus enzalutamide
  • Placebo plus enzalutamide
  • Birmingham, Alabama
  • +306 more
Jan 18, 2023

Early Breast Cancer Trial in United States (TALAZOPARIB)

Terminated
Has Results
  • Early Breast Cancer
  • TALAZOPARIB
  • Gilbert, Arizona
  • +96 more
Oct 11, 2021

mCRPC Trial in Worldwide (Talazoparib with enzalutamide, Placebo with enzalutamide)

Active, not recruiting
  • mCRPC
  • Talazoparib with enzalutamide
  • Placebo with enzalutamide
  • Anchorage, Alaska
  • +363 more
Aug 3, 2022

Extensive Stage Lung Small Cell Carcinoma Trial in United States (Atezolizumab, Talazoparib)

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Anchorage, Alaska
  • +564 more
Jan 28, 2023

Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)

Completed
Has Results
  • Breast Neoplasms
  • +2 more
  • Flagstaff, Arizona
  • +361 more
Dec 20, 2021

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer

Active, not recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +4 more
  • Mobile, Alabama
  • +324 more
Sep 21, 2021

Solid Tumor Trial in United States (Talazoparib)

Completed
Has Results
  • Solid Tumor
  • Talazoparib
  • Bakersfield, California
  • +18 more
Dec 13, 2019

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation Trial in Canada, United States (Laboratory Biomarker Analysis,

Completed
Has Results
  • ATM Gene Mutation
  • +20 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +1156 more
Jun 22, 2021

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Korea Post Marketing Surveillance (PMS) Study of Talzenna®

Not yet recruiting
  • Breast Neoplasms
  • (no location specified)
Aug 1, 2022

Advanced Solid Tumors Trial in Budapest (Talazoparib)

Completed
Has Results
  • Advanced Solid Tumors
  • Talazoparib
  • Budapest, Hungary
    PRA Magyarorszag Kft, Fazis I-es Klinikai Farmakologiai Vizsgalo
May 25, 2018

Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to

Completed
  • Cancer
  • PARP Inhibitors
  • Caen, Basse Normandie, France
    Alexandre Joachim
Mar 9, 2021

Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor
  • PARP inhibitor BMN-673
  • +4 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 22, 2022

Ovarian Cancer Trial (Talazoparib, Temozolomide)

Withdrawn
  • Ovarian Cancer
  • (no location specified)
Sep 14, 2018

Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,

Recruiting
  • Neoadjuvant Therapy
  • +3 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022

Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib)

Terminated
Has Results
  • Breast Neoplasms
  • +2 more
  • talazoparib
  • Greenbrae, California
  • +70 more
Oct 10, 2019

Endometrial Cancer Trial in United Kingdom (BMN 673)

Withdrawn
  • Endometrial Cancer
  • BMN 673
  • Brighton, East Sussex, United Kingdom
  • +15 more
Aug 5, 2021

Triple Negative Breast Cancer Trial in Spain (Carboplatin, Gemcitabine, Nadunolimab)

Recruiting
  • Triple Negative Breast Cancer
  • Málaga, Andalucía, Spain
  • +11 more
Feb 15, 2022

Immunotherapy Trial in France (olaparib, durvalumab, tremelimumab)

Recruiting
  • Immunotherapy
  • olaparib, durvalumab, tremelimumab
  • Amiens, France
  • +7 more
May 21, 2021

Treating Recurrent Stage IV Squamous Cell Lung Cancer

Active, not recruiting
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
  • Birmingham, Alabama
  • +1003 more
Nov 29, 2021

Breast Cancer Trial in France (Main study:, Sub-study:)

Recruiting
  • Breast Cancer
  • Main study:
  • Sub-study:
  • Bordeaux, France
  • +20 more
Jan 2, 2023